2024 M&A Year in Review - Flipbook - Page 37
M&A Year in Review | 2024
We advised Orlando Health, a not-for-profit health care system,
on its acquisition of three hospitals and related physician
practices from Steward Health Care, the largest physicianled, integrated health care system in the United States.
This transaction was part of Steward’s Chapter 11
bankruptcy proceeding, one of the largest and most
complex hospital bankruptcy proceedings ever filed.
Lawyers from our health care, M&A, and restructuring
teams in our Los Angeles, New York, Silicon Valley, and
Washington, D.C. offices led the transaction, with support
from several U.S. offices and our antitrust, employee
benefits, employment, environment, intellectual property,
litigation, privacy and cybersecurity, private equity, real
estate, regulatory, and tax practices.
We advised Recordati, an international pharmaceutical
company, on its acquisition of the global rights to
Enjaymo® (sutimlimab) from Sanofi, a multinational
pharmaceutical company, for a consideration of US $825
million plus additional commercial milestone payments
of up to US $250 million.
The transaction aligns with Recordati’s broader strategy,
reaffirms its commitment to the rare diseases space, and
complements its oncology portfolio.
Lawyers in our Milan, Washington, D.C., and Baltimore
offices led the transaction, with support from our Düsseldorf,
Frankfurt, London, Los Angeles, New York, Rome, and
Tokyo offices and our employee benefits, employment,
intellectual property, regulatory, and tax practices.
37
